|
Volumn 29, Issue 2, 2006, Pages 480-
|
Cost-effectiveness of self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: Response to davidson [26]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
INSULIN;
ANTIDIABETIC AGENT;
GLYCOSYLATED HEMOGLOBIN;
BLOOD GLUCOSE MONITORING;
CLINICAL TRIAL;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
COST MINIMIZATION ANALYSIS;
COST OF ILLNESS;
GLUCOSE BLOOD LEVEL;
HEALTH CARE;
HUMAN;
LETTER;
META ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
SELF MONITORING;
SYSTEMATIC REVIEW;
UNITED KINGDOM;
BLOOD;
ECONOMICS;
NOTE;
GERMANY;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
PATIENT CARE;
PATIENT PARTICIPATION;
BLOOD GLUCOSE SELF-MONITORING;
DIABETES MELLITUS, TYPE 2;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
|
EID: 33646377907
PISSN: 01495992
EISSN: 01495992
Source Type: Journal
DOI: 10.2337/diacare.29.02.06.dc05-1857 Document Type: Letter |
Times cited : (12)
|
References (4)
|